Adage Capital Partners GP L.L.C. Has $13 Million Stock Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Adage Capital Partners GP L.L.C. increased its stake in Acadia Healthcare by 69%, now holding approximately $13 million worth of 428,580 shares.
• Acadia Healthcare reported a 9.2% year-over-year revenue increase with earnings per share of $0.83, beating analysts' expectations.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Acadia Healthcare, with an average price target of $40.77.

Adage Capital Partners GP L.L.C. grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 69.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 428,580 shares of the company's stock after buying an additional 175,000 shares during the period. Adage Capital Partners GP L.L.C. owned approximately 0.47% of Acadia Healthcare worth $12,995,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. lifted its holdings in Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock valued at $202,000 after purchasing an additional 622 shares during the last quarter. LPL Financial LLC lifted its holdings in shares of Acadia Healthcare by 1.2% during the first quarter. LPL Financial LLC now owns 56,527 shares of the company's stock worth $1,651,000 after buying an additional 697 shares in the last quarter. Quantinno Capital Management LP lifted its holdings in shares of Acadia Healthcare by 9.0% during the fourth quarter. Quantinno Capital Management LP now owns 8,695 shares of the company's stock worth $345,000 after buying an additional 721 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in shares of Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after buying an additional 812 shares in the last quarter.

Acadia Healthcare Trading Up 6.0%

Shares of ACHC stock traded up $1.27 during mid-day trading on Thursday, reaching $22.33. 1,402,228 shares of the stock traded hands, compared to its average volume of 2,228,493. The stock's fifty day simple moving average is $22.16 and its two-hundred day simple moving average is $24.55. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $79.82. The company has a market cap of $2.06 billion, a price-to-earnings ratio of 14.80, a price-to-earnings-growth ratio of 4.58 and a beta of 0.89. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period last year, the firm posted $0.91 earnings per share. The business's revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Cowen restated a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Barclays decreased their price target on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. UBS Group decreased their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Finally, KeyCorp decreased their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $39.00.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.